Synopsis of recent research by authors named "Anil K Mondru"
- Anil K Mondru's recent research primarily focuses on understanding cellular signaling pathways, particularly the ERK5 and BCR signaling pathways, and their roles in cancer development and treatment resistance, as illustrated in studies on melanoma and chronic lymphocytic leukemia (CLL).
- His work showcases the investigation of therapeutic agents, such as the synthesis of a novel ruthenium-phloretin complex, which demonstrates potential reprogramming of the breast cancer microenvironment through modulation of key signaling pathways including PI3K/Akt/mTOR/VEGF.
- Mondru also explores the impact of compounds like sodium selenate and methoxy VO-salen on diabetes-related oxidative stress and renal impairment, emphasizing the significance of these substances in improving cell survival and functional outcomes in diabetic models.
